Call Us + 33 1 84 88 31 00

Article R4211-35 of the French Public Health Code

The Director General of the Agence nationale de sécurité du médicament et des produits de santé will send a copy of the complete application to the Director General of the Agence de la biomédecine for his opinion. The Director General of the Agence de la biomédecine will send his opinion to the Director General of the Agence nationale de sécurité du médicament et des produits de santé within two months…

Read More »

Article R4211-36 of the French Public Health Code

I. – The Director General of the Agence nationale de sécurité du médicament et des produits de santé will notify the applicant of his decision within ninety days from the date of receipt of the application accompanied by a file containing all the documents mentioned in the decision provided for in Article R. 4211-34. The Director General may request any additional information or carry out an investigation to enable him…

Read More »

Article R4211-37 of the French Public Health Code

Applicant establishments or organisations appoint a responsible person who ensures compliance with the regulations relating to the quality and safety of advanced therapy medicinal products prepared on an ad hoc basis, and one or more interim responsible persons who are entrusted with the same powers and duties as those conferred on the responsible person for the period of the replacement and actually exercise them for the duration of the replacement….

Read More »

Article R4211-38 of the French Public Health Code

The person in charge referred to in Article R. 4211-37, the interim persons in charge, the person in charge of site activities and the interim person in charge of site activities must hold the qualifications required to practise medicine or pharmacy or hold a doctorate in the life and health sciences. The persons mentioned in the first paragraph must have qualifications and practical experience of at least two years in…

Read More »

Article R4211-39 of the French Public Health Code

The establishment or authorised body must send the Director General of the Agence nationale de sécurité du médicament et des produits de santé a copy of any instrument appointing the responsible person referred to in Article R. 4211-37 and the interim responsible person or persons. When the responsible person or the acting responsible person is temporarily or permanently replaced, the authorised establishment or body immediately informs the Director General of…

Read More »

Article R4211-40 of the French Public Health Code

To avoid any risk of cross-contamination, where storage, preparation and transfer activities for scientific purposes are carried out on the same premises as those dedicated to the preparation, storage, distribution and transfer of advanced therapy medicinal products prepared on an ad hoc basis, the establishment or organisation applying for authorisation must put in place procedures to ensure compliance with health and safety rules and separate circuits according to the purpose…

Read More »

Article R4211-41 of the French Public Health Code

Applicant establishments or organisations are required to have: 1° Premises fitted out, arranged and maintained in accordance with the rules of good practice provided for in the first or third paragraph of Article L. 5121-5 and, where applicable, in accordance with the containment requirements adopted in application of Article L. 532-1 of the Environmental Code; 2° Staff whose skills and qualifications comply with these rules of good practice; 3° Equipment…

Read More »

Article R4211-42 of the French Public Health Code

I. – With the exception of the establishments and organisations mentioned in II and III, any establishment or organisation benefiting from the authorisation provided for in this section shall put in place agreements or procedures with another establishment or other establishments or organisations authorised under this section, ensuring that in the event of interruption or cessation of activity, advanced therapy medicinal products prepared on an ad hoc basis and, where…

Read More »

Article R4211-42-1 of the French Public Health Code

I.-Establishments or organisations that prepare or import investigational advanced therapy medicinal products prepared on an ad hoc basis ensure that all preparation operations are carried out in accordance with the information provided by the sponsor in the application for authorisation referred to in article L. 1123-8 and accepted by the Agence nationale de sécurité du médicament et des produits de santé. II.-The importing establishment or organisation ensures that the investigational…

Read More »

Article R4211-43 of the French Public Health Code

I. – Substantial changes to the activities authorised in application of this section which relate to: – the preparation of a new pharmaceutical form of an advanced therapy medicinal product prepared on a one-off basis; – the preparation of a new pharmaceutical form of an advanced therapy medicinal product prepared on a one-off basis; – the preparation of a new pharmaceutical form of an advanced therapy medicinal product prepared on…

Read More »

Contact a French lawyer now

Contact a French Business Lawyer

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.

Useful links

You have a question in French Business Law?

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.

All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.